Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599075 · ClinicalTrials.gov registry record · Phase 4
Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus
A Phase 4 study of Type 1 Diabetes and Pregnancy, High Risk, sponsored by Gianna Wilkie.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04599075 is a Phase 4 study of Type 1 Diabetes and Pregnancy, High Risk that has completed, run by Gianna Wilkie. The registered enrollment target is 70 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04599075, a Phase 4 study of Type 1 Diabetes and Pregnancy, High Risk, has completed, sponsored by Gianna Wilkie.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to perform a randomized trial to investigate if intrapartum insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous insulin infusion with regard to the primary outcome of neonatal blood sugar.
Conditions Studied
Interventions
- DRUG Insulin
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2023-05-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04599075
The ClinicalTrials.gov registry entry for NCT04599075 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is Gianna Wilkie, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Insulin is the first listed.
NCT04599075 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04599075 about?
NCT04599075 is a clinical study titled "Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus". The purpose of this study is to perform a randomized trial to investigate if intrapartum insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous insulin infusion with regard to th...
What is the current status of trial NCT04599075?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2021-03-15. Estimated completion is 2023-05-02.
What conditions does trial NCT04599075 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Pregnancy, High Risk.
What interventions are being tested in trial NCT04599075?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT04599075?
This trial is sponsored by Gianna Wilkie, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04599075 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Extended Bolus for Meals in a Closed-loop System
RECRUITING · Phase 4
-
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
RECRUITING · Phase 4
-
Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
COMPLETED · Phase 4
-
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
COMPLETED · Phase 4
-
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
COMPLETED · Phase 4
-
A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.